Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4
Alzheimer's & Dementia · 2025-07 · 21 (7)
DOI: 10.1002/alz.70483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.07.2025. Verfasst von Klara Gawor und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging and Pathology, Laboratory of Neuropathology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Hippocampus, Cognitive Dysfunction. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, KU Leuven Onderzoeksraad, Alzheimer's Association.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION In neurodegenerative dementias, the co‐occurrence and interaction of amyloid β peptide (Aβ), tau pathology, and other pathological lesions confound their individual contributions to neurodegeneration and their modulation by risk factors. METHODS We analyzed 480 post mortem human brains (ages 50–99) using regression and structural equation models to assess the relationships among Aβ, tau, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), α‐synuclein, other age‐related lesions, and apolipoprotein E ( APOE ) ε4, as well as their effects on CA1 neuronal density, brain weight, and cognitive status. RESULTS Aβ, tau, LATE‐NC, and amygdala‐predominant α‐synuclein pathology were mutually interdependent. Tau was the strongest predictor of global neurodegeneration, while LATE‐NC primarily, but not exclusively, affected hippocampal neuron loss. Small vessel disease correlated with both LATE‐NC and α‐synuclein, while APOE ε4 was mainly associated with extracellular parenchymal and capillary Aβ pathology. DISCUSSION Although Alzheimer's disease pathology plays a central role in brain degeneration, coexisting pathologies can both exacerbate and independently contribute to it. These factors should be considered in patient stratification. Highlights In aging individuals, amyloid β peptide (Aβ), tau pathology, limbic‐predominant age‐related TDP‐43 encephalopathy neuropathological changes (LATE‐NC), and amygdala‐predominant α‐synuclein pathology were interrelated but contributed independently to neurodegeneration. LATE‐NC was the strongest driver of CA1 neuronal loss, while tau burden was the strongest predictor of global brain degeneration. Apolipoprotein E ε4 was associated with both extracellular and capillary Aβ deposits, but not with tau burden. Temporal lobe small vessel disease was associated with both LATE‐NC and amygdala‐predominant α‐synuclein pathology. Neural network models can reliably identify hippocampal pyramidal neurons on hematoxylin‐stained histological slides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Imaging and Pathology, Laboratory of Neuropathology, KU Leuven, Leuven, Belgium.
- Department of Neuroscience, Laboratory of Neurobiology, KU Leuven, Leuven, Belgium.
- Department of Human Genetics, Laboratory of Multi-omic Integrative Bioinformatics, KU Leuven, Leuven, Belgium.
- Laboratory of Neuropathology, Institute of Pathology, Ulm University, Ulm, Germany.
- Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
- Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
ORCID-Profile: Klara Gawor, Sam Verrept, Geethika Arekatla, David Wouters, Alicja Ronisz, Celeste Laureyssen, Bas Lahaije, Christine A F von Arnim, Bernard Hanseeuw, Rik Vandenberghe, Matthew Blaschko, Alejandro Sifrim, Kristel Sleegers, Dietmar Rudolf Thal, Sandra O Tomé
Förderung
- Fonds Wetenschappelijk Onderzoek
- KU Leuven Onderzoeksraad
- Alzheimer's Association
- Deutsche Forschungsgemeinschaft
- Alzheimer Forschung Initiative
- BrightFocus Foundation
- German Federal Ministry of Education and Research
- Boehringer Ingelheim Ulm University BioCenter
Zitieren
APA
Gawor, K., Verrept, S., Arekatla, G., Wouters, D., Ronisz, A., Hecht, M., Laureyssen, C., Donck, H. V., Lahaije, B., Ospitalieri, S., Vandenbulcke, M., Otto, M., von Arnim, C. A. F., Ghebremedhin, E., Hanseeuw, B., Vandenberghe, R., Blaschko, M., Sifrim, A., Sleegers, K., …, & Tomé, S. O. (2025). Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4. Alzheimer's & Dementia, 21(7). https://doi.org/10.1002/alz.70483
Vancouver
Gawor K, Verrept S, Arekatla G, Wouters D, Ronisz A, Hecht M, et al. Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4. Alzheimer's & Dementia. 2025;21(7). doi:10.1002/alz.70483
BibTeX
@article{Gawor2025,
author = {Gawor, Klara and Verrept, Sam and Arekatla, Geethika and Wouters, David and Ronisz, Alicja and Hecht, Moritz and Laureyssen, Celeste and Donck, Helena Ver and Lahaije, Bas and Ospitalieri, Simona and Vandenbulcke, Mathieu and Otto, Markus and von Arnim, Christine A F and Ghebremedhin, Estifanos and Hanseeuw, Bernard and Vandenberghe, Rik and Blaschko, Matthew and Sifrim, Alejandro and Sleegers, Kristel and Thal, Dietmar Rudolf and Tomé, Sandra O},
title = {Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {7},
doi = {10.1002/alz.70483}
}
EUVIMED